Connection

Xiaoming Yang to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications Xiaoming Yang has written about Aged, 80 and over.
Xiaoming Yang
Connection Strength
0.025
Aged, 80 and over
  1. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.